![Marcelle Machluf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcelle Machluf
Founder at NanoGhost Ltd.
Marcelle Machluf active positions
Companies | Position | Start | End |
---|---|---|---|
Technion-Israel Institute of Technology | Corporate Officer/Principal | - | - |
NanoGhost Ltd.
![]() NanoGhost Ltd. Packaged SoftwareTechnology Services NanoGhost Ltd. is an Israeli biotech company that specializes in developing a drug delivery platform called Nano-Ghosts/NGs. The company is based in Netanya, Israel. The platform is highly selective and is derived from the cell membrane of mesenchymal stem cells (MSCs), which have a known affinity for cancer and sites of inflammation. The company was founded in 2019 by Marcelle Machluf. Yonatan Malca has been the CEO of the company since 2019. | Director/Board Member | 2019-08-13 | - |
Founder | 2019-08-13 | - |
Career history of Marcelle Machluf
Former positions of Marcelle Machluf
Companies | Position | Start | End |
---|---|---|---|
ERECH FINANCE CAHALACHA LTD | Director/Board Member | 2010-10-26 | 2019-10-26 |
Independent Dir/Board Member | 2010-10-26 | 2019-10-26 |
Training of Marcelle Machluf
Ben-Gurion University of the Negev | Doctorate Degree |
The Hebrew University of Jerusalem | Undergraduate Degree |
Statistics
International
Israel | 6 |
Operational
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ERECH FINANCE CAHALACHA LTD | Health Technology |
Private companies | 1 |
---|---|
NanoGhost Ltd.
![]() NanoGhost Ltd. Packaged SoftwareTechnology Services NanoGhost Ltd. is an Israeli biotech company that specializes in developing a drug delivery platform called Nano-Ghosts/NGs. The company is based in Netanya, Israel. The platform is highly selective and is derived from the cell membrane of mesenchymal stem cells (MSCs), which have a known affinity for cancer and sites of inflammation. The company was founded in 2019 by Marcelle Machluf. Yonatan Malca has been the CEO of the company since 2019. | Technology Services |
- Stock Market
- Insiders
- Marcelle Machluf
- Experience